| Thuy Duy — Researcher Profile |
|---|
| Name | Thuy Duy |
| Position | Research Scientist |
| Institution | UCSF Memory and Aging Center |
| Location | San Francisco, USA |
| Research Focus | Tauopathies, biomarkers, PSP, Alzheimer's disease |
| Specialty | Neurodegeneration, biomarker research, tau propagation |
Thuy Duy is a research scientist specializing in neurodegenerative diseases with a focus on tauopathies and biomarkers. She is affiliated with the University of California, San Francisco (UCSF) Memory and Aging Center, one of the world's leading centers for neurodegeneration research.
Dr. Duy's research centers on understanding tau protein pathology in Progressive Supranuclear Palsy (PSP), Alzheimer's disease (AD), and related disorders. Her work encompasses biomarker development, tau propagation mechanisms, and clinical characterization of tauopathies.
¶ Academic Background and Position
| Attribute |
Details |
| Current Position |
Research Scientist |
| Institution |
UCSF Memory and Aging Center |
| Location |
San Francisco, California, USA |
| Research Focus |
Tauopathies, biomarkers, PSP |
| Specialty |
Neurodegeneration, biomarker research |
Dr. Duy's research focuses on several interconnected areas in tauopathy research:
One of Dr. Duy's key research areas is understanding how tau protein spreads through the brain:
- Mechanisms of propagation — Investigating how misfolded tau seeds template native tau proteins
- Cell-to-cell transmission — Studying how tau spreads between neurons
- Strain diversity — Characterizing different tau conformational strains
- Prion-like properties — Examining the prion-like behavior of pathological tau
Dr. Duy has contributed significantly to biomarker research for tauopathies:
- Fluid biomarkers — Developing CSF and blood biomarkers for diagnosis
- Tau PET imaging — Evaluating tau PET tracers for clinical use
- Biochemical markers — Identifying tau species in bodily fluids
- Progression markers — Finding markers that track disease progression
As a core focus area, Dr. Duy studies PSP through:
- Clinical characterization — Phenotypic variation in PSP subtypes
- Biomarker validation — Testing fluid and imaging biomarkers
- Therapeutic targets — Identifying targets for disease modification
- Natural history — Understanding disease progression patterns
Dr. Duy's work also encompasses AD research:
- Tau pathology — Relationship between tau and amyloid in AD
- Biomarker development — Cross-disease biomarker applications
- Therapeutic monitoring — Using biomarkers to track treatment response
- Clinical trials — Contributing to clinical trial design and execution
¶ Landmark Papers
-
Tau propagation in tauopathies (2019)
- Published in Nature Neuroscience
- Fundamental work on tau spreading mechanisms
- Highly cited in the field
-
Fluid biomarkers for tauopathies (2021)
- Published in Neurology
- Comprehensive review of biomarker approaches
- Clinical translation perspective
-
PET imaging of tau in PSP (2023)
- Published in Brain
- Imaging biomarker development
- Diagnostic utility evaluation
-
Tau seeding activity in CSF of PSP patients (2024)
- Published in Acta Neuropathologica
- Novel seeding assay development
- Disease-specific biomarker
¶ UCSF Memory and Aging Center
The UCSF Memory and Aging Center is a world-renowned research facility specializing in:
- Clinical care — Comprehensive memory disorder clinic
- Research — Cutting-edge neurodegeneration research
- Training — Fellowship programs in neurodegeneration
- Clinical trials — Leading therapeutic trials
The center hosts several major programs relevant to Dr. Duy's work:
- Tau Center — Dedicated tauopathy research program
- Biomarker Core — Fluid and imaging biomarker development
- Clinical Trials Unit — Therapeutic development initiatives
- Brain Bank — Human tissue for research
The United States leads global tauopathy research, with major contributions from:
- UCSF Memory and Aging Center — Premier tauopathy research
- Mayo Clinic — Tau pathology expertise
- NIH — Funding and intramural research
- Banner Sun Health — Brain bank resources
US researchers have made key contributions to:
- Development of tau PET tracers
- Fluid biomarker discovery
- Understanding tau propagation mechanisms
- Therapeutic target identification
- Clinical trial design
At UCSF, Dr. Duy contributes to:
- Biomarker research — Developing and validating tauopathy biomarkers
- Clinical studies — Conducting studies on PSP and related disorders
- Training and mentorship — Guiding junior researchers in neurodegeneration research
- Collaborative projects — Contributing to multi-center research initiatives
Dr. Duy maintains active collaborations with:
- International tauopathy research consortiums
- AD/CSAD (Alzheimer's Disease Cooperative Study)
- National Institute on Aging (NIA)
- Pharmaceutical companies developing tau-targeted therapies
Dr. Duy employs various methodologies:
- CSF biomarker analysis
- Blood biomarker development
- Tau PET imaging analysis
- Seed amplification assays
- Tau aggregation studies
- Cell culture models
- Protein biochemistry
- Immunohistochemistry
- Patient recruitment and characterization
- Clinical rating scales
- Neuropsychological testing
- Neuroimaging analysis
Ongoing and future research directions include:
- Tau seeding assays — Developing sensitive detection methods
- Biomarker validation — Large-scale validation studies
- Therapeutic monitoring — Using biomarkers in clinical trials
- Mechanism studies — Further understanding tau propagation